| Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma Patients (NCT05252078) | Jiangxi Provincial Cancer Hospital | 2022-06-02 |
| XELOX Combined With Anlotinib and Penpulimab vs XELOX as Adjuvant Therapy in ctDNA Positive Gastric and Esophagogastric Junction Adenocarcinoma (NCT05494060) | The First Affiliated Hospital with Nanjing Medical University | 2022-03-16 |
| Research on the Application and Mechanism of New Biological Probes in Biomedicine (NCT04977739) | Nanfang Hospital, Southern Medical University | 2021-08-03 |
| Spanish Series of Patients Treated With the Radionuclide Lutetium177 (NCT04949282) | Sociedad Española de Medicina Nuclear e Imagen Molecular | 2021-05-10 |
| A Study of HTD1801 in Adolescents With Primary Sclerosing Cholangitis (PSC) (NCT03678480) | HighTide Therapeutics (Hong Kong) Limited | 2021-03-01 |
| A Phase 1, Multicenter, Open-Label Study to Evaluate the Effect of Mild or Moderate Hepatic Impairment on the Multiple-Dose Pharmacokinetics of Ozanimod (NCT04639115) | Celgene | 2020-12-18 |
| Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable Metastases (NCT05322486) | State Scientific Centre of Coloproctology, Russian Federation | 2020-10-29 |
| Efficacy and Safety of SOX Regimen Combined With Camrelizumab as Neoadjuvant Treatment in Locally Advanced Gastric Cancer: a Phase II, Single-arm Study (NCT05602935) | The Second Affiliated Hospital of Fujian Medical University | 2020-09-16 |
| Anlotinib Hydrochloride Capsules Combined With CAPEOX in RAS and BRAF Wild-type mCRC Patients (NCT04080843) | Zhejiang University | 2019-11-15 |
| Strategies for Hepatitis C Testing and Treatment in Aboriginal Communities That Lead to Elimination (NCT03776760) | Kirby Institute | 2019-05-28 |
| A Study of HTD1801 in Adults With Nonalcoholic Steatohepatitis (NASH) and Type 2 Diabetes Mellitus (T2DM) (NCT03656744) | HighTide Biopharma Pty Ltd | 2018-11-26 |
| Evaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma (NCT03717298) | Catalysis SL | 2018-10-30 |
| Bioequivalence Study of Nexvax2 in Subjects With Celiac Disease (NCT03543540) | ImmusanT, Inc. | 2018-05-01 |
| Combination of Radiation Therapy and Peptide Specific CTL Therapy in Treating Patients With Esophageal Cancer (NCT03011255) | Shixiu Wu | 2016-12-01 |
| Point of Care 3D Ultrasound for Various Applications: A Pilot Study (NCT02831556) | Duke University | 2016-07-01 |
| Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative Colitis (NCT02647866) | Kyowa Kirin, Inc. | 2016-06-01 |
| Efficacy and Safety of Grazoprevir (+) Uprifosbuvir (+) Ruzasvir (MK-3682B) (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021) (NCT02613403) | Merck Sharp & Dohme LLC | 2015-12-10 |
| Effect of Probiotic and Smectite Gel on NAFLD (NCT03614039) | Nazarii Kobyliak | 2015-09-15 |
| Safety and Immunogenicity of Recombinant Hepatitis B Vaccines in the Neonates (NCT02764671) | Shenzhen Kangtai Biological Products Co., LTD | 2015-05-01 |
| Opioid Effects on Cognitive Function Following Colonoscopy (NCT02267681) | Perihan Ekmekçi | 2014-10-01 |
| Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers (NCT02503631) | Exact Sciences Corporation | 2014-10-01 |
| Sample Collection Study to Evaluate DNA Markers in Subjects With Inflammatory Bowel Disease (IBD) (NCT02503696) | Exact Sciences Corporation | 2014-09-01 |
| PK and PD Study of IDN-6556 in Subjects With Hepatic Impairment and Matched Healthy Volunteers (NCT02121860) | Conatus Pharmaceuticals Inc. | 2014-04-01 |
| Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study) (NCT01964430) | Celgene | 2014-03-28 |
| Non-anesthesiologist Administered Propofol Sedation for Colonoscopy - a Randomized Clinical Trial (NCT02067065) | Hospital Beatriz Ângelo | 2014-01-01 |
| Efficacy and Safety Study of Tripterygium Glycoside in the Treatment of Crohn's Disease for Induction Remission (NCT02044952) | Zhu Weiming | 2014-01-01 |
| Evolution® Biliary Stent System Clinical Study (NCT01962168) | Cook Group Incorporated | 2013-12-01 |
| Molecular, Pathologic and MRI Investigation of the Prognostic and Redictive Importance of Extramural Venous Invasion in Rectal Cancer (MARVEL) Trial (NCT01995942) | Royal Marsden NHS Foundation Trust | 2013-06-07 |
| Efficacy of a Multi-strain Probiotic in the Treatment of Irritable Bowel Syndrome (NCT01887834) | The Canadian College of Naturopathic Medicine | 2013-06-01 |
| Efficacy and Tolerability of NM-BL in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis (NCT01710644) | Nordmark Arzneimittel GmbH & Co. KG | 2013-05-01 |
| 89Zr-MMOT PET Imaging in Pancreatic and Ovarian Cancer Patients (NCT01832116) | University Medical Center Groningen | 2013-03-01 |
| Warm Water and Unsedated Colonoscopy (NCT01463319) | Presidio Ospedaliero Santa Barbara | 2011-11-01 |
| Exact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation Testing (NCT01600209) | Exact Sciences Corporation | 2011-10-01 |
| Special Investigation of LipaCreon on Long-term Use in Patients With Pancreatic Exocrine Insufficiency (NCT01427725) | Mylan Inc. | 2011-09-01 |
| Special Investigation (All Cases) of LipaCreon in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis (NCT01427712) | Mylan Inc. | 2011-08-01 |
| Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer (NCT01397747) | Exact Sciences Corporation | 2011-06-01 |
| Phase I Study to Investigate the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of CJ-12406 in Healthy Male Subjects (NCT01489774) | HK inno.N Corporation | 2011-05-01 |
| Efficacy of a Multi-strain Probiotic in the Treatment of Irritable Bowel Syndrome (IBS) (NCT01176227) | The Canadian College of Naturopathic Medicine | 2010-05-01 |
| Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC) (NCT01009593) | Abbott | 2010-01-01 |
| Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks (NCT01037049) | Royal Marsden NHS Foundation Trust | 2009-10-16 |
| A Study to Examine the Human Gastrointestinal Tract Using the Confocal Endomicroscope (NCT01262937) | Yale University | 2009-07-01 |
| Epidemiological Study in Children and Adolescents With Chronic Hepatitis B (NCT01163240) | Novartis Pharmaceuticals | 2009-06-01 |
| Open Label Safety Study of DCI-1020 in Pediatric Cystic Fibrosis (CF) Patients (NCT00663975) | Digestive Care, Inc. | 2009-02-01 |
| Endoscopic Submucosal Dissection for Gastrointestinal Neoplasms (NCT01378507) | Chinese PLA General Hospital | 2009-01-01 |
| Confocal Laser Endomicroscopy in Digestive Diseases (NCT01156064) | Chinese PLA General Hospital | 2008-08-01 |
| Transit Time and Bacterial Overgrowth Using SmartPill Capsule (NCT00577772) | Mayo Clinic | 2007-11-01 |
| Low Rectal Cancer Study (MERCURY II) (NCT02005965) | Royal Marsden NHS Foundation Trust | 2007-08-13 |
| Confocal Laser Endomicroscopy (NCT00561938) | Nantes University Hospital | 2007-06-01 |
| Abnormal Expression Proteins, Mitochondrial DNA and miRNA of Irritable Bowel Syndrome (NCT01028898) | Chinese PLA General Hospital | 2006-01-01 |
| Therapy Study of Automated Protocolized vs. Physician-Directed Non-Protocolized Weaning (NCT00606788) | University of Luebeck | 2005-11-01 |
| Development of an Evaluation Method of Elderly Condition in Patient Receiving Chemotherapy Treatment (NCT00210249) | Institut Bergonié | 2002-09-01 |